Pre-earnings options volume in Capricor Therapeutics (CAPR) is normal with calls leading puts 9:2. Implied volatility suggests the market is anticipating a move near 8.9%, or $1.07, after results are released. Median move over the past eight quarters is 8.8%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Promising Long-Term Efficacy of Capricor’s Deramiocel in DMD Spurs Buy Rating
- Capricor Therapeutics announces long-term data from HOPE-2 OLE study
- Capricor Therapeutics receives FDA acceptance of BLA for deramiocel
- Biotech Alert: Searches spiking for these stocks today
- Capricor Therapeutics call volume above normal and directionally bullish
Questions or Comments about the article? Write to editor@tipranks.com